BioPharmSignal logoBioPharmSignal

Biotech News

Certara Announces CFO Transition

Certara (CERT)Certara2026-06-25 13:46 ESTCompany update

Reaffirms 2026 Guidance RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief Financial Officer, has notified the Company of his intent to resign from his office effective as of the end

Open original release

Related news

CERTCertara2026-06-25 13:46 EST

Certara Reports First Quarter 2026 Financial Results

CERTCertara2026-06-25 13:46 EST

Certara Automates Scientific Workflows with Phoenix® Cloud

CERTCertara2026-06-25 13:46 EST

Certara Reports Third Quarter 2025 Financial Results

CERTCertara2026-06-25 13:46 EST

Certara Appoints Jon Resnick as Chief Executive Officer

CERTCertara2026-06-25 13:46 EST

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026

CERTCertara2026-06-25 13:46 EST

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

CERTCertara2026-06-25 13:46 EST

Certara to Participate in Upcoming Investor Conferences

CERTCertara2026-06-25 13:46 EST

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

CERTCertara2026-06-25 13:46 EST

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

CERTCertara2026-06-25 13:46 EST

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

View all latest news

Certara

Certara is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

CERTCertara2026-06-26 10:01 EST

Certara Announces CFO Transition

CERTCertara2026-06-26 10:01 EST

Certara Reports First Quarter 2026 Financial Results

CERTCertara2026-06-26 10:01 EST

Certara Automates Scientific Workflows with Phoenix® Cloud

CERTCertara2026-06-26 10:01 EST

Certara Reports Third Quarter 2025 Financial Results

CERTCertara2026-06-26 10:01 EST

Certara Appoints Jon Resnick as Chief Executive Officer

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States